Evidence map›Paper›PMID 28052131›Full record

ArticlePloS one2017

Two Antagonistic MALT1 Auto-Cleavage Mechanisms Reveal a Role for TRAF6 to Unleash MALT1 Activation.

Stefanie Ginster, Maureen Bardet, Adeline Unterreiner, Claire Malinverni, Florian Renner, Stephen Lam, Felix Freuler, Bertran Gerrits, Johannes Voshol, Thomas Calzascia and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. MALT1 substrate cleavage: what is it good for?Frontiers in immunology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Ways and waves of MALT1 paracaspase activation.Cellular & molecular immunology · 2018
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Stefanie GinsterNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Maureen BardetNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Adeline UnterreinerNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Claire MalinverniNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Florian RennerNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Stephen LamNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Felix FreulerNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Bertran GerritsNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Johannes VosholNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Thomas CalzasciaNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Catherine H RégnierNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Martin RenatusNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Rainer NikolayNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Laura IsraëlNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Frédéric BornancinNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Novartis (Switzerland) · CHNovartis Institutes for BioMedical Research

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The paracaspase MALT1 has arginine-directed proteolytic activity triggered by engagement of immune receptors. Recruitment of MALT1 into activation complexes is required for MALT1 proteolytic function. Here, co-expression of MALT1 in HEK293 cells, either with activated CARD11 and BCL10 or with TRAF6, was used to explore the mechanism of MALT1 activation at the molecular level. This work identified a prominent self-cleavage site of MALT1 isoform A (MALT1A) at R781 (R770 in MALT1B) and revealed that TRAF6 can activate MALT1 independently of the CBM. Intramolecular cleavage at R781/R770 removes a C-terminal TRAF6-binding site in both MALT1 isoforms, leaving MALT1B devoid of the two key interaction sites with TRAF6. A previously identified auto-proteolysis site of MALT1 at R149 leads to deletion of the death-domain, thereby abolishing interaction with BCL10. By using MALT1 isoforms and cleaved fragments thereof, as well as TRAF6 WT and mutant forms, this work shows that TRAF6 induces N-terminal auto-proteolytic cleavage of MALT1 at R149 and accelerates MALT1 protein turnover. The MALT1 fragment generated by N-terminal self-cleavage at R149 was labile and displayed enhanced signaling properties that required an intact K644 residue, previously shown to be a site for mono-ubiquitination of MALT1. Conversely, C-terminal self-cleavage at R781/R770 hampered the ability for self-cleavage at R149 and stabilized MALT1 by hindering interaction with TRAF6. C-terminal self-cleavage had limited impact on MALT1A but severely reduced MALT1B proteolytic and signaling functions. It also abrogated NF-κB activation by N-terminally cleaved MALT1A. Altogether, this study provides further insights into mechanisms that regulate the scaffolding and activation cycle of MALT1. It also emphasizes the reduced functional capacity of MALT1B as compared to MALT1A.

Indexed as

Adaptor Proteins, Signal TransducingB-Cell CLL-Lymphoma 10 ProteinBlotting, WesternCARD Signaling Adaptor ProteinsCaspasesCell LineCells, CulturedElectrophoresis, Polyacrylamide GelGuanylate CyclaseHEK293 CellsHumansImmunoblottingJurkat CellsLymphocytesMucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinMutagenesisAdaptor Proteins, Signal TransducingB-Cell CLL-Lymphoma 10 ProteinBCL10 protein, humanCARD11 protein, humanCARD Signaling Adaptor ProteinsCaspasesGuanylate CyclaseMALT1 protein, humanMucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinNeoplasm ProteinsProtein IsoformsTNF Receptor-Associated Factor 6

Identifiers

PMID28052131
PMCPMC5214165
OpenAlexW2569743124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.